Definitive salvage chemotherapy for the treatment of refractory/relapsed non-Hodgkin lymphoma, a single center experience
ConclusionGDP is as effective as DHAP for relapsed or refractory lymphoma with less toxicity and better quality of life.
Source: Alexandria Journal of Medicine - Category: General Medicine Source Type: research
More News: Cancer & Oncology | Chemotherapy | Dexamethasone | General Medicine | Hodgkin's Disease | Lymphoma | Non-Hodgkin's Lymphoma | Statistics | Study | Toxicology